Funded Biotechnology Startups
Among the 50 most recent disclosed biotechnology rounds shown, the largest disclosed amount is $250M for Nuvation Bio (2026-06-25), which dwarfs most other…
Among the 50 most recent disclosed biotechnology rounds shown, the largest disclosed amount is $250M for Nuvation Bio (2026-06-25), which dwarfs most other disclosed rounds in the list (e.g., Beeline Medicines at $126M on 2026-06-30, Flare Therapeutics at $85M on 2026-06-30, and many rounds clustered in the ~$1M–$50M range). Several large fundraises also appear near this top end: April Bio ($124M, 2026-06-25) and Beeline Medicines ($126M, 2026-06-30) sit in the same broad magnitude band as other double-digit, while a smaller tail includes $200K Magdent (2026-06-24) and other sub-$1M/low-$M entries.
The list is tightly time-bounded: all rows fall between 2026-06-24 and 2026-06-30, with a dense set of 2026-06-25 closings across multiple countries. Geographic clustering is noticeable around US biotech hubs, especially California (e.g., Flare Therapeutics in Cambridge, CA; Oblenio Bio in Oakland; and Imagion Biosystems in Albuquerque), while stage labels skew heavily toward “Series Unknown” (33 of 50), with only a smaller number carrying named stages (e.g., Series A: Beeline Medicines $126M on 2026-06-30; Series D: Lycia Therapeutics $75M on 2026-06-25). Two rounds list “undisclosed” amounts (smartbax on 2026-06-30 and Solarferm on 2026-06-24).
Most recent rounds
50 of 4,1684,118 more funded startups
This page shows the 50 most recent rounds (back to Jun 2026). The full 4,168-company history for this listing is available on a paid plan.
Unlock all 4,168 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What’s the largest disclosed round in this biotechnology slice, and how far above the rest does it sit?
The top disclosed amount is Nuvation Bio’s $250M on 2026-06-25; the next-largest disclosed amounts shown are in the ~$100M–$130M band (Beeline Medicines $126M on 2026-06-30, April Bio $124M on 2026-06-25), while many other disclosed rounds are $50M or below (e.g., Pyxis Oncology $50M on 2026-06-30; Helus Pharma $50M on 2026-06-24).
Are there a lot of closings in a narrow recent window, and which date acts like a focal point?
Yes. Every shown round falls between 2026-06-24 and 2026-06-30, and 2026-06-25 alone includes many sizable entries (e.g., 4D Molecular Therapeutics is 2026-06-29, while 2026-06-25 includes April Bio $124M, Nuvation Bio $250M, and Oblenio Bio $62M).
Which entries look like outliers on the low end among disclosed amounts?
The smallest disclosed amount is Magdent at $150K (2026-06-24). That sub-$1M floor is followed by other low disclosed rounds such as Andon Bio $250K (2026-06-29) and multiple ~$1M–$4M deals (e.g., Oblique Therapeutics $1M on 2026-06-30; Thalia Therapeutics $4M on 2026-06-24).
Does stage labeling cluster, or is there a dominant ‘unknown’ classification?
Stage labels are dominated by “Series Unknown”: 33 of the 50 rows. Named stages appear but in smaller pockets, such as Series A (Beeline Medicines $126M on 2026-06-30; RQ Bio $113M on 2026-06-24; Anodyne Nanotech $13M on 2026-06-24), and Series D (Lycia Therapeutics $75M on 2026-06-25; TISSIUM $34M on 2026-06-24).
Are there notable geographic clusters by city or state across these recent rounds?
California appears repeatedly in the US entries (e.g., Flare Therapeutics in Cambridge, Massachusetts is not California; but the list includes Imagion Biosystems in Albuquerque, New Mexico, while California-based examples include Oblenio Bio in Oakland at $62M on 2026-06-25, and multiple US entries around the West Coast such as Mesoblast in Melbourne, so it’s better summarized as recurring US hub concentration rather than one single city). Notably, the UK is also recurring with multiple London-area entries (e.g., Concert Bio in London on 2026-06-29 at $130K and RQ Bio in Leiden rather than London, while RQ Bio is in Leiden, and Sera Prognostics is Salt Lake City), so the strongest pattern is recurring US states and multiple European countries rather than one dominant city name across every row.
Within this list, how many rounds are labeled ‘undisclosed,’ and are there any other close comparable low-visibility cases?
Two rounds list “undisclosed” amounts: smartbax ($0 disclosed) on 2026-06-30 and Episurf Medical ($0 disclosed) on 2026-06-26, plus Solarferm ($0 disclosed) on 2026-06-24. By contrast, even very small disclosed rounds still show explicit amounts like Magdent $150K (2026-06-24) and Andon Bio $250K (2026-06-29).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.